logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Fosun Pharma (02196.HK) repurchased 320,000 shares for approximately HK$5.2536 million on October 30.

date
30/10/2026
Zhitong Finance APP News, Fosun Pharma (02196.HK) announced that on October 30, 2026, the company spent approximately HK$5.2536 million to repurchase 320,000 shares at a repurchase price of HK$16.09 to HK$16.5 per share.
Latest
2 m ago
7Road (00797.HK) cancels 4.234 million repurchased shares
2 m ago
Abbisko-B (02256.HK) repurchased 80,000 shares on October 30 for approximately HK$496,600.
3 m ago
Tuhu-W (09690.HK) repurchased 343,000 shares on October 30 for approximately HK$3.976 million.
3 m ago
Zheshang Bank (02016.HK) reported a net profit attributable to shareholders of RMB 11.78 billion for the first three quarters, up 0.96% year on year.
3 m ago
Compton (603798.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 52.34 million yuan, a year-on-year decrease of 4.41%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.